Gain-of-function mutations, which increase the basal activity of NF-κB, have been associated with the pathogenesis of BS or EOS20, 21, whereas some loss-of-function mutations have been correlated with susceptibility to CD18, 19. Here, ITGB2 is linked to Bloom syndrome.